Valeant and Pershing Square announce merger proposal with Allergan

Canada-based Valeant Pharmaceuticals and US-based Pershing Square Capital Management have disclosed details of their offer to purchase Botox-maker Allergan for more than $45bn.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news